Lv0
0 积分 2023-05-30 加入
FGFR3 Destabilizes PD-L1 Via NEDD4 to Control T Cell-Mediated Bladder Cancer Immune Surveillance
1天前
已完结
Role of FGFR3 in bladder cancer: Treatment landscape and future challenges
1天前
已完结
Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study
2天前
已完结
Exploring the Flare Phenomenon in Patients with Castration-Resistant Prostate Cancer: Enzalutamide-Induced PSMA Upregulation Observed on PSMA PET
14天前
已完结
Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial
14天前
已完结
Prostate-Specific Membrane Antigen–Targeted Therapies for Prostate Cancer: Towards Improving Therapeutic Outcomes
19天前
已完结
Prostate cancer treatment – China's perspective
19天前
已完结
The biology and rationale of targeting nectin-4 in urothelial carcinoma
1个月前
已完结
The function of Prostate Health Index in detecting clinically significant prostate cancer in the PI-RADS 3 population: a multicenter prospective study
1个月前
已完结
Advances in PSMA-targeted therapy for prostate cancer
2个月前
已完结
皖公网安备34019202002308
